retatrutide triple agonist peptide Best (Triple Agonist) Reta GLP-3R (Retatrutide) 10mg |

Here's how the leading options compare

In: McNeill JH (ed)

As the first drug approved for this indication since 2014, semaglutide has been deemed practice changing, since it showed a reduction in body weight of approximately 15-18% across four phase 3 trials [23]

This target trial emulation study compared GLP-1RAs with two other medications used in diabetes treatment: sodium-glucose cotransporter-2 inhibitors (SGLT2is) and dipeptidyl peptidase-4 inhibitors (DPP4is)

Their use is individualized, dosage-specific, and accompanied by medical oversight

doi: 10.1056/NEJMcp1113996 [DOI] [PubMed] [Google Scholar] 76.Green R